Literature DB >> 11438899

Risk factors for anaerobic bloodstream infections in bone marrow transplant recipients.

R L Lark1, S A McNeil, K VanderHyde, Z Noorani, J Uberti, C Chenoweth.   

Abstract

The incidence of anaerobic bloodstream infections (BSI) in patients who underwent bone marrow transplantation (BMT) recently increased at our institution. A retrospective case-control study of patients undergoing BMT from January 1995 through December 1998 was performed to determine the microbiological characteristics, epidemiology, and outcome of anaerobic BSI and to identify independent risk factors for infection. Anaerobic BSI occurred in 23 patients, for a rate of 4 BSIs per 100 BMT procedures, and it accounted for 17% of all BSIs that occurred during the study period. Infection occurred at a mean (+/- standard deviation) of 7+/-4 days after BMT and 7+/-5 days after the onset of neutropenia. Fusobacterium nucleatum was the most frequently isolated pathogen (in 17 patients), followed by Leptotrichia buccalis (in 4), Clostridium septicum (in 1), and Clostridium tertium (in 1). Two case patients (9%) died. Severity of mucositis was an independent predictor of anaerobic BSI (odds ratio, 4.4; P=.01). Controlling mucositis is critical for the prevention of anaerobic BSI in this patient population.

Entities:  

Mesh:

Year:  2001        PMID: 11438899     DOI: 10.1086/322595

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  19 in total

1.  A fulminant enterocolitis.

Authors:  Nael Moussa; Dominique Decré; Jean-Luc Baudel; Georges Offenstadt; Eric Maury
Journal:  Dig Dis Sci       Date:  2007-04-06       Impact factor: 3.199

2.  Production of indole from L-tryptophan and effects of these compounds on biofilm formation by Fusobacterium nucleatum ATCC 25586.

Authors:  Takako Sasaki-Imamura; Akira Yano; Yasuo Yoshida
Journal:  Appl Environ Microbiol       Date:  2010-05-14       Impact factor: 4.792

3.  Mobilization and prevalence of a Fusobacterial plasmid.

Authors:  Brianna M Claypool; Sean C Yoder; Diane M Citron; Sydney M Finegold; Ellie J C Goldstein; Susan Kinder Haake
Journal:  Plasmid       Date:  2009-09-15       Impact factor: 3.466

Review 4.  A systematic review of dental disease management in cancer patients.

Authors:  Catherine H L Hong; Shijia Hu; Thijs Haverman; Monique Stokman; Joel J Napeñas; Jacolien Bos-den Braber; Erich Gerber; Margot Geuke; Emmanouil Vardas; Tuomas Waltimo; Siri Beier Jensen; Deborah P Saunders
Journal:  Support Care Cancer       Date:  2017-07-22       Impact factor: 3.603

5.  Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation.

Authors:  Ajay K Nooka; Heather R Johnson; Jonathan L Kaufman; Christopher R Flowers; Amelia Langston; Conor Steuer; Michael Graiser; Zahir Ali; Nishi N Shah; Sravanti Rangaraju; Dana Nickleach; Jingjing Gao; Sagar Lonial; Edmund K Waller
Journal:  Biol Blood Marrow Transplant       Date:  2014-03-06       Impact factor: 5.742

6.  Leptotrichia bacteremia in patients receiving high-dose chemotherapy.

Authors:  Marc Roger Couturier; E Susan Slechta; Claudia Goulston; Mark A Fisher; Kimberly E Hanson
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

7.  Five-year retrospective epidemiological survey of anaerobic bacteraemia in a university hospital and rewiew of the literature.

Authors:  E Urbán
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-06-13

8.  A phase I dose-escalation trial of high-dose melphalan with palifermin for cytoprotection followed by autologous stem cell transplantation for patients with multiple myeloma with normal renal function.

Authors:  Muneer H Abidi; Rishi Agarwal; Nishant Tageja; Lois Ayash; Abhinav Deol; Zaid Al-Kadhimi; Judith Abrams; Simon Cronin; Marie Ventimiglia; Lawrence Lum; Voravit Ratanatharathorn; Jeffrey Zonder; Joseph Uberti
Journal:  Biol Blood Marrow Transplant       Date:  2012-08-11       Impact factor: 5.742

9.  Leptotrichia amnionii sp. nov., a novel bacterium isolated from the amniotic fluid of a woman after intrauterine fetal demise.

Authors:  Sanjay K Shukla; Paul R Meier; Paul D Mitchell; Daniel N Frank; Kurt D Reed
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

10.  Febrile neutropenia and Fusobacterium bacteremia: clinical experience with 13 cases.

Authors:  P Fanourgiakis; M Vekemans; A Georgala; D Daneau; A Vandermies; P Grenier; M Aoun
Journal:  Support Care Cancer       Date:  2003-03-13       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.